Dietary Intervention in Dyslipidemia

Abstract

Get full access to this article

View all access options for this article.

References

McPherson

Frohlich

Fodor

Canadian Cardiovascular Society Position Statement — recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiology 2006;22(11):913–27.

Park

Harris

. Omega-3 fatty acid supplementation accelerates chylomycron triglyceride clearance. J Lipid Res 2003;44:455–63.

Kris-Etherton

Harris

Appel

. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular diseases. Circulation 2002;106:2747–57.

Song

Daviglus

Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004;109:2705–11.

Whelton

Muntner

. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 2004;93:1119–23.

Hooper

Thompson

Harrison

Risks and benefits of omega-3 fats for mortality, cardiovascular disease and cancer: systematic review. BMJ 2006;332:752–60.

Järvinen

Knekt

Rissanen

Reunanen

. Intake of fish and long-chain n-3 fatty acids and the risk of coronary heart mortality in men and women. Br J Nutr 2006;95:824–9.

Davis

Kris-Etherton

. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am J Clin Nutr 2003;78(3 Suppl):640S–646S.

Bucher

Hengstler

Schindler

Meier

. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298–304.

10.

Harris

. N-3 fatty acids and serum lipoprotein: human studies. Am J Clin Nutr 1997;65(5 suppl):1645S–54S.

11.

Contacos

Barter

Sullivan

. Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arterioscler Thromb 1993;13:1755–62.

12.

Nordoy

Bonaa

Nilsen

Effects of simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. J Intern Med 1998;243:163–70.

13.

Nies

Cymbala

Kasten

Complementary and alternative therapies for the management of dyslipidemia. Ann Pharmacother 2006;40:1984–92.

14.

Jones

. Clinical nutrition: 7. Functional foods — more than just nutrition. CMAJ 2002;166(12):1555–63.

15.

Liu

Stampfer

Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 1999;70:412–9.

16.

Bazzano

Ogden

Dietary fibre intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 2003;163:1897–904.

17.

Pereira

O'Reilly

Augustsson

Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 2004;164:370–6.

18.

Fletcher

Berra

Ades

Managing abnormal blood lipids: a collaborative approach. Circulation 2005;112:3184–209.

19.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA 2001;285:2486–97.

20.

Anderson

Allgood

Lawrence

Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 2000;71(2):472–9.

21.

Van Horn

McCoin

Kris-Etherton

The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc 2008;108:287–331.

22.

Sacks

Lichtenstein

Van Horn

Soy protein, isoflavones and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006;113:1034–44.